11 Glass Extratcables Bayer Zuercher
-
Upload
daniel-lopez-vazquez -
Category
Documents
-
view
36 -
download
2
Transcript of 11 Glass Extratcables Bayer Zuercher
Glass Extractables
Dr. Jörg Zürcher, Global Pharmaceutical Development/ Packaging Development
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
• Composition of glass
• Pharmacopoeial requirements
• Examples for extractables/leachables
• Risk evaluation of glass extractables
• Concepts to avoid extractables/leachables
• Summary and conclusions
Content
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Composition of different glass types
source: Schott-Rohrglas GmbH, Mitterteich
borosilicateglass
neutral glass(tubes)
neutral glass(molded)
soda-limeglass
SiO2 80 - 82 72 - 75 65 - 70 70 - 75
B2O3 12 - 13 9 - 11 9 - 11 0 - 1
Al2O3 2 5 - 7 3 - 7 2 - 4
Na2O/K2O 4 6 - 9 9 - 10 12 - 16
MgO/CaO/BaO 0 1 - 3 4 - 5 10 – 15
molding temp. (°C) 1260 1145 - 1170 1050 - 1080 1015 - 1045
Composition of glass
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Function of glass ingredients:
SiO2 backbone structure
CaO increasing hardness & chemical resistance
Al2O3 increasing chemical resistance
Na2O, B2O3 lowering melting point
Composition of glass
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Structure of borosilicate-glass
Silicon
Oxygen
Boron
Sodium
Aluminum
Composition of glass
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Ph.Eur.
3.2.1. GLASS CONTAINERS FOR PHARMACEUTICAL USE
Classifies glass types according to hydrolytic resistance:
• type I: They are of neutral glass of high hydrolytic resistance due to the chemical composition of the glass itself
• type II: They are usually of soda-lime-silica glass and have high hydrolytic resistance resulting from suitable treatment of the surface
• type III: They are usually of soda-lime-silica glass and have only moderate hydrolytic resistance
Pharmaceutical requirements
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Ph.Eur.
3.2.1. GLASS CONTAINERS FOR PHARMACEUTICAL USE
Test methods for glass containers:
• Testing for hydrolytic resistance– surface hydrolytic resistance test– powdered glass test– hydrolytic resistance test of the etched surface
• Arsenic (applies to containers for aqueous parenterals only)
• Light transmission • Resistance to thermal shock
• Resistance to centrifugation
Pharmaceutical requirements
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
USP
<660> CONTAINERS - GLASS
Classifies glass types according to hydrolytic resistance:
• type I: high resistant, borosilicate glass
• type II: treated soda-lime glass
• type III: soda-lime glass
• type NP: general-purpose soda-lime glass
Pharmaceutical requirements
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
USP
<660> CONTAINERS - GLASS
Test methods for glass containers:
• Testing for hydrolytic resistance– surface hydrolytic resistance test– powdered glass test
• Arsenic
• Light transmission
Pharmaceutical requirements
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
JP 15
7.01 Test for Glass Containers for injections
Test methods for glass containers:
• Testing for hydrolytic resistance– powdered glass test < 100 ml filling volume– surface hydrolytic resistance test > 100 ml filling volume
• Soluble iron
• Light transmission
Pharmaceutical requirements
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Method comparison - glass powder test
Ph. Eur. USP JP
mesh width (µm) 250 - 425 300 - 425 300 - 850
mass glass powder (g) 20 10 5
water volume (ml) 100 50 50
autoclavation cycle 121°C/ 30 min RT 121°C/ 19-23 min121°C/ 30 min
121°C RT/ 38-46 min
100°C/ 120 min
titration volume (ml) 50 50 50
titration medium 0.01 N HCl 0.02 N H2SO4 0.01 M H2SO4
indicator methyl red methyl red bromcresol green-methyl red
limit (ml)glass type Iglass type II/IIIglass type IV/NP
≤ 2.0≤ 17.0≤ 30.0
≤ 1.0≤ 8.5≤ 15.0
limits notcomparable withPh.Eur. and USP
Pharmaceutical requirements
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Method comparison - surface test
Ph. Eur. USP JP
fillvolume for testing nominal filling capacity 90 % of overflowcapacity
90 % of overflowcapacity
autoclavation cycle 100°C/ 10 min100°C 121°C/ 20 min
121°C/ 60 min121°C 100°C/ 40 min
titration after max. 1h
RT 121°C/ 19-23 min121°C/ 60 min
121°C RT/ 38-46 min
121°C/ 60 min
titration volume (ml) ≤ 3 ml: 25> 3 – 30 ml: 50
> 30 ml: 100
100 100
titration medium 0.01 N HCl 0.02 N H2SO4 0.01 M H2SO4
indicator methyl red methyl red bromcresol green-methyl red
limits (ml) depending on containervolume
≤ 100 ml: ≤ 0.7> 100 ml: ≤ 0.2
> 100 ml: ≤ 2
Pharmaceutical requirements
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Alkali release - influence of filling volume and storage time
source: Dr. J. Pfeifer, Schott-Rohrglas GmbH, DPhG Fachgruppentagung Analytik 2003
0
1
2
3
4
5
6
7
8
0 1 2 3 4 5 6 7 8
storage period (years)
ppm
sod
ium
oxi
de
0.5 ml filling 1 ml filling
Examples for extractables/ leachables
Test conditions
1 ml ampoules with WFI
filling volumes: 0.5 and 1 ml
autoclaving at 121°C for 20 minutes
store at 25°C/65%RH
measurement of Na2O by flame photometry
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Silica release - influence of filling
source: Dr. E. Spingler-Kloess, Swiss Pharma, 10/99, p. 11ff
0
10
20
30
40
50
60
70
80
Lactic
acid
Acetic
acid
Ascor
bic ac
id
Malic a
cidTart
aric a
cid
Oxalic
acid
Glucuro
nic ac
id
Citric
acid
cont
ent S
i (pp
m)
Examples for extractables/ leachables
Test conditions
glass type II containers
autoclaving at 121°C for 60 minutes
measurement of Si by AAS
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Silica release - influence of pH-value
source: Dr. E. Spingler-Kloess, Swiss Pharma, 10/99, p. 11ff
-5
0
5
10
15
20
25
30
35
40
3 4 5 6 7 8 9
pH-value
Si re
leas
ed (p
pm)
Examples for extractables/ leachables
Test conditions
2 ml ampoules
autoclaving at 121°C for 60 minutes
filling: citrate buffer adjusted to the respective pH-value
measurement of Si by AAS
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Alkali release might induce pH-shift of an unbuffered filling
• reduced shelf-life
• precipitation of product ingredients
Silicon release might induce glass flaking or delamination
• increasing particle load
Risk evaluation of extractables/ leachables
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Surface treatment - glass type III type II
• relevant for molded glass containers
• (NH4)2SO4 is injected before annealing:
reaction:
(NH4)2SO4 (NH4)HSO4 + NH3
2Na+ + (NH4)HSO4 Na2SO4 + NH3 + 2 H+
• the water soluble Na-salt on the glass surface is removed by rinsing
Concepts to avoid extractables/ leachables
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Surface treatment - glass type III type II
• surface treatment with (NH4)2SO4 can also be used for glass type I containers to reduce the increased alkali release after molding
Concepts to avoid extractables/ leachables
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Surface treatment - treatment of glass type I
source: Dr. J. Pfeifer, Schott-Rohrglas GmbH, DPhG Fachgruppentagung Analytik 2003
0
1
2
3
4
5
6
7
8
0 1 2 3 4 5 6 7 8storage period (years)
ppm
sod
ium
oxi
de
treateduntreated
Concepts to avoid extractables/ leachables
Test conditions
1 ml ampoules treated and untreated
Treatment (NH4)2SO4
filling volumes: 0.5 (WFI)
autoclaving at 121°C for 20 minutes
store at 25°C/65%RH
measurement of Na2O by flame photometry
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Siliconization of container surface
• siliconized surfaces are hydrophobic reducing the wettability of the container surface
• thus siliconized glass surfaces are reducing potential interactions with aqueous fillings
• the release of alkali ions is reduced compared to non-siliconized containers
• but: potential silicone oil contamination of the filling needs to be considered
Concepts to avoid extractables/ leachables
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Coating of inner surface
• SCHOTT Type I plus®
Concepts to avoid extractables/ leachables
source: Schott - Product brochure SCHOTT Type I plus®
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Coating of inner surface
Evaluation: autoclaving at 121°C for 6h, AAS-analysis:
type I type I plus®
Na+ 3.5 ppm < 0.01 ppm
Ca2+ 1.1 ppm < 0.05 ppm
B3+ 3.5 ppm < 0.1 ppm
Si4+ 5.0 ppm < 0.3 ppm
Al3+ 2.3 ppm < 0.05 ppm
Concepts to avoid extractables/ leachables
source: Schott - Product brochure SCHOTT Type I plus®
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
Extractables/leachables from glass are inorganic components of the glass bulk material
• major extractables: Si and Na
• minor extractables: K, B, Ca, Al
• trace extractables: Fe (in colored glass)
Relatively low levels of extractables are found in fillings at pH 4-8, much greater levels for fillings with pH > 9
Summary and conclusions
Glass Extractables, December 2009, SCHOTT Pharma Symposium Mainz
The composition of the filling impacts the extent of extraction,especially:
• pH, type of buffer system, surfactants, complexing agents
Container size, fill volume and storage conditions are also influencing the mass of extractables
Manufacturing processes (e.g. sterilization time and temperature) impact the extent of extraction
Viable concepts to reduce extractables are surface treatment and coatings
Summary and conclusions
Thank you for your attention